Biotech bubble may just be an optical illusion
By iCELL News on March 27, 2015 · Sector
SAN FRANCISCO (MarketWatch)—The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse.“There are optics suggesting that […]
It was a tumultuous week. Investors should get used to it because volatility is going to be with us for some time to come. You can blame a lot of things, but the evidence suggests that the dollar is the main culprit behind the market’s gyrations.The rate of ascent, rather than the direction of the dollar, is largely to blame […]
Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors’ Stock Buyback Follows a Worrying Trend:
General Motors’ announcement that it will buy back $5 billion worth of stock raises the question of whether the stock buyback has turned into a shareholder activist shakedown.G.M. did not open its […]
Hear that hissing noise?That’s the air coming out of the stock market.Here’s what’s happening and what to do about it…U.S. stocks are plummeting supposedly because Saudi Arabia launched airstrikes against Yemen, which has retaliated by lobbing missiles into Saudi Arabia. Saudi Arabia, you know, where all the oil is.In the Middle East the Saudi market took a 5% hit yesterday. […]
Dear Reader,US tech and biotech stocks are in a bubble. I expect a 30% sell off in these two segments of the US stock market within 2015. The main US stock indices to sell off 20% from current levels.EUR/USD to target 0.90 in 2015. Gold to fall to 1050 USD in 2015.European stocks to also sell off 20% from current […]
Wikimedia CommonsThere is probably a bubble in biotech stocks. In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what it […]
View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks.
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]
Wikimedia CommonsThere is probably a bubble in biotech stocks. In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what it […]
View gallery.(Wikimedia Commons)There is probably a bubble in biotech stocks.
In a big note on published on Friday, analysts at Credit Suisse ask if we’re in a biotech bubble, and answer that no, it’s not a bubble, merely a “new era” for biotech stocks. Which is exactly what it sounds like when something is a bubble. Credit Suisse hinges its argument on what […]
Credit Suisse on Biotech’s Nirvana Phase
Posted March 27, 2015 by Joshua M Brown
There’s a really interesting piece of research out from Credit Suisse in which Ravi Mehrotra & Co lay out an “It’s different this time” thesis that seeks to explain why the huge rally in biotech stocks is justified and possibly not over yet.
They note that there are indeed […]
